Open access
Aug 2026
Beyond GLP-1: Charting the Future of Peptide Therapeutics in Metabolic Disease
The next generation of metabolic therapeutics should be judged not by maximal short-term weight loss alone, but by durable health gain across organs, function, quality of life, and populations.
B. Pezeshki, Mojtaba Farjam, A. Karimi
· Galen medical journal · 0 citations